Kamada (KMDA) Return on Capital Employed Growth (1y) (2019 - 2026)
Kamada (KMDA) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 89.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,195.00 |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 589,349.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 589,349.00 |
| Dec 31, 2025 | 572,555.00 |
| Sep 30, 2025 | 582,906.00 |
| Jun 30, 2025 | 438,666.00 |
| Mar 31, 2025 | 792.00 |
| Dec 31, 2024 | 797.00 |
| Sep 30, 2024 | 425.00 |
| Jun 30, 2024 | 28,641.00 |
| Mar 31, 2024 | -89,036.00 |
| Dec 31, 2023 | -104,388.00 |
| Sep 30, 2023 | -81,716.00 |
| Jun 30, 2023 | 114,655.00 |
| Mar 31, 2023 | 89,387.00 |
| Dec 31, 2022 | 104,502.00 |
| Sep 30, 2022 | 81,591.00 |
| Jun 30, 2022 | -1,170.00 |
| Mar 31, 2022 | -1,245.00 |
| Dec 31, 2021 | -1,277.00 |
| Sep 30, 2021 | -987.00 |
| Jun 30, 2021 | -367.00 |